Tag : genome sequencing

LogicBio® Therapeutics, Inc. (Nasdaq: LOGC), a clinical-stage genetic medicine company, today reported financial results for the year ended December 31, 2021, and provided business updates. “At LogicBio, we...

Genomic Testing Cooperative, LCA (GTC) announced today that their hematology molecular profiling is expanded to cover analysis of the UBA1 and NFE2 genes. Both genes were...

Mapmygenome India opened its Genomics Experience Center in Bengaluru on March 1. The NABL & ICMR certified center is located at Sector 7, HSR Layout. The new...

Inaugural program offers scientific entrepreneurs the opportunity to receive up to $1 million of funding to create and grow new ventures around promising genomic and...

ERS Genomics announced today that the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (“PTAB”) confirmed that its decision regarding priority of invention...

The “Genome Editing Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Technology, Application, and End User” report has been added to ResearchAndMarkets.com’s offering. The genome editing...

Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a partnership with 10x Genomics, a life sciences leader focused on...

NextGen Jane, a genomics startup generating big data for novel applications in molecular diagnostics and drug development for female reproductive disorders, announced that it has...

Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a collaboration and co-marketing partnership with Jumpcode Genomics that validates Jumpcode’s...

The C2intelligence Platform enables custom, cost-effective, efficient, automatic, and globally accessible cancer data management and real-time monitoring. Based on a recent industry analysis, Frost & Sullivan recognizes C2i...